Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy
Kalisvar MarimuthuCaPES Study Group

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) can be mechanistically classified into carbapenemase-producing Enterobacteriaceae (CPE) and non-carbapenemase-producing carbapenem nonsusceptible Enterobacteriaceae (NCPCRE). We sought to investigate the effect of antecedent carbapenem exposure as a risk factor for NCPCRE versus CPE. Among all patients with CRE colonization and infection, we conducted a case-control study comparing patients with NCPCRE (cases) and patients with CPE (controls). The presence of carbapenemases was investigated with phenotypic tests followed by PCR for predominant carbapenemase genes. We included 843 unique patients with first-episode CRE, including 387 (45.9%) NCPCRE and 456 (54.1%) CPE. The resistance genes detected in CPEs were blaNDM (42.8%), blaKPC (38.4%), and blaOXA-48-like (12.1%). After adjusting for confounders and clustering at the institutional level, the odds of prior 30-day carbapenem exposure was three times higher among NCPCRE than CPE patients (adjusted odds ratio [aOR], 3.48; 95% confidence interval [CI], 2.39 to 5.09; P < 0.001). The odds of prior carbapenem exposure and NCPCRE detection persisted in stratified analyses by Enterobacteriaceae species (Klebsiella pneumoniae and Escheric...Continue Reading

References

Oct 6, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S HarbarthM H Samore
Jul 17, 2007·Clinical Microbiology Reviews·Anne Marie Queenan, Karen Bush
Feb 14, 2009·Journal of Clinical Microbiology·Azita LeavittShiri Navon-Venezia
Oct 8, 2009·American Journal of Public Health·Gaby JudahVal Curtis
Jan 16, 2013·Antimicrobial Agents and Chemotherapy·Laurence Armand-LefèvreAntoine Andremont
Feb 5, 2013·BMC Infectious Diseases·Michelle N D BalmJeanette W P Teo
Jan 1, 2012·Western Pacific Surveillance and Response Journal : WPSAR·Jeanette TeoRaymond Lin
Dec 7, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mitchell J Schwaber, Yehuda Carmeli
Dec 18, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E TacconelliUNKNOWN European Society of Clinical Microbiology
Jul 24, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hilary HumphreysBrian J Harvey
May 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yiying CaiKalisvar Marimuthu
May 6, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kalisvar MarimuthuUNKNOWN Carbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) Study Group
Mar 20, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sarah M BartschBruce Y Lee
May 3, 2018·Antimicrobial Resistance and Infection Control·Daniel J LivorsiEli N Perencevich
Nov 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara TomczykStephan Harbarth

❮ Previous
Next ❯

Citations

Jul 1, 2020·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Aiman BandaliGregory Malat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Nederlands tijdschrift voor geneeskunde
Marjan van ApeldoornJayant Kalpoe
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Audrey EmeryXavier Bertrand
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Kyu-Ri KimSang-Ho Choi
© 2021 Meta ULC. All rights reserved